Nemera and SCHOTT Pharma deliver verified pen injector platform with sterile cartridge system

• Nemera’s pen injector platform verified with SCHOTT Pharma’s cartriQ^® 3 mL ready-to-use glass cartridge system
• Compatibility testing confirms seamless and reliable integration of delivery device and primary packaging, ensuring optimal device performance and patient safety
• Partnership supports growing demand for patient-centric injectable therapies in homecare settings

To support the industry shift from hospital to homecare including a more convenient drug administration for patients, Nemera, a world-leading provider of drug delivery device solutions and combination product services, and SCHOTT Pharma, a pioneer in drug containment solutions and delivery systems, have strengthened their partnership to provide pharmaceutical companies with a reliable, fully verified platform for injectable therapies.

“As healthcare increasingly moves closer to patients, pharmaceutical companies need to combine drug containment and delivery from the outset,” says Christian Mias, CEO of SCHOTT Pharma. “Together with Nemera, we are helping them address this growing demand through a proven and compatible platform solution.”

“Our collaboration with SCHOTT Pharma reflects our commitment to providing integrated drug delivery solutions that help simplify development and accelerate time to market”, says Marc Hämel, CEO of Nemera. “At Nemera, we believe that strong partnerships are essential to helping pharmaceutical companies bring combination products to patients more efficiently.”

Strategic partnership to address evolving patient needs

As therapeutic combination products require seamless integration between the delivery device and the pharmaceutical primary packaging system, Nemera’s and SCHOTT Pharma’s partnership supports optimal product performance as well as patient safety and comfort.

With more than…

To access the full Press Release: Click HERE